Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Critical Care

<< Previous

Bullboard Posts

Next >>

Comment by ChesterLiveson Feb 22, 2024 4:28pm

123 Views

Post# 35894310

RE:RE:RE:Critical Care

According to Critical Care, 15 investigators and Dr. Kellum say the data is extremely favourable... beyond favourable, BULLET PROOF.

Bashers have a ton of ammo today. That is the company's fault! I expect every personality out in full force and they don't disappoint.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing